Akchuli Medical

Akchuli Medical is a China-based medical technology company specializing in the development of innovative interventional cryoablation systems. The company focuses on treating cardiovascular diseases, particularly atrial fibrillation, through its proprietary cryoballoon and cryoablation catheter technologies. Akchuli's platform aims to provide safer and more efficient alternatives to traditional radiofrequency ablation for cardiac arrhythmias. The company has secured significant venture capital funding from prominent investors to advance its clinical trials and structural heart portfolio. Currently, Akchuli is positioning itself as a leading domestic player in the Chinese electrophysiology market by targeting the displacement of imported ablation technologies.